PROCEPT BioRobotics Corp. PRCT 深 沪
已收盘 02-06 16:00:00 美东时间
28.74
+1.340
+4.89%
华盛通- 最 高28.775
- 今 开27.50
- 成交量 148.87万股
- 最 低 26.655
- 昨 收 27.40
- 总市值 16.06亿
- 52周最高 70.80
- 市盈率 静 --
- 换手率 2.66%
- 52周最低 26.655
- 委 比 -64.87%
- 总股本 5587.86万
- 历史最高 103.8099
- 量 比 1.29
- 振 幅 7.74%
- 历史最低 15.38
- 每 手 1
- 风险率 12.70%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多美股大行评级 | 潜在涨幅101%！12家机构集体上调美光目标价；Insmed、RPM、Vital Farms等遭多家大行下调评级
今日重点评级关注：Ascendiant Capital：维持Society Pass"买入"评级，目标价从22美元升至22.5美元；HC Wainwright & Co.：维持Climb Bio"买入"评级，目标价从9美元升至11美元
2025-12-19 10:15
美股大行评级 | 博通、Lululemon获10逾家大行上调目标价；好市多、RH遭大行下调目标价
今日重点评级关注：杰富瑞：维持ImmunityBio Inc Ordinary Shares"买入"评级，目标价从8美元升至9美元；B. Riley证券：维持WAVE Life Sciences"买入"评级，目标价从19美元升至37美元
2025-12-15 15:30
UBS Initiates Coverage On PROCEPT BioRobotics with Buy Rating, Announces Price Target of $62
UBS analyst Danielle Antalffy initiates coverage on PROCEPT BioRobotics (NASDAQ:PRCT) with a Buy rating and announces Price Target of $62.
2025-12-13 00:13
美股大行评级 | 潜在涨幅2566.67%！Ascendiant Capital上调GRI Bio目标价至36美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从35美元升至36美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.75美元升至8美元
2025-12-09 10:32
美股大行评级 | 最高500美元！MongoDB获18家大行紧急上调目标价；巴克莱下调理想汽车目标价至18美元
今日重点评级关注：B. Riley证券：维持Seabridge Gold"买入"评级，目标价从50美元升至65美元；HC Wainwright & Co.：维持TRX Gold"买入"评级，目标价从1.2美元升至1.4美元
2025-12-03 09:58
Morgan Stanley Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $51
Morgan Stanley analyst Patrick Wood maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price target from $56 to $51.
2025-12-03 01:52
PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
PROCEPT BioRobotics will present at the 37th Annual Piper Sandler Healthcare Conference on December 2, 2025, in New York City. A live webcast and archived recording will be available on the company’s website. PROCEPT BioRobotics, focused on advancing urology care, develops robotic solutions like the HYDROS Robotic System for Aquablation therapy, designed to treat BPH-related LUTS. The therapy offers effective, safe outcomes regardless of prostate...
2025-11-20 21:03
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
2025-11-06 09:55
Wells Fargo Maintains Overweight on PROCEPT BioRobotics, Lowers Price Target to $51
Wells Fargo analyst Nathan Treybeck maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Overweight and lowers the price target from $58 to $51.
2025-11-05 23:26
美股大行评级 | 贝莱德、花旗、摩根大通、富国银行均获上调目标价！汇丰上调超微公司目标价升至310美元
今日重点评级关注：Roth Capital：维持Cingulate"买入"评级，目标价从10美元升至17美元；JMP证券：维持BioCryst Pharma"跑赢大市"评级，目标价从17美元升至27美元
2025-10-16 10:43
